Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Rational design and characterization of the novel, broad and potent bispecific HIV-1 neutralizing antibody iMabm36.

Rational design and characterization of the novel, broad and potent bispecific HIV-1 neutralizing antibody iMabm36. . 2014 Aug 15; 66(5):473-83.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.